Gritstone Bio shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $6 to $7.
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler has maintained an Overweight rating on Gritstone Bio and raised its price target from $6 to $7. This has led to Gritstone Bio's shares trading higher.
September 28, 2023 | 3:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler's maintained Overweight rating and increased price target for Gritstone Bio has resulted in the company's shares trading higher.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, Piper Sandler's maintained Overweight rating and increased price target for Gritstone Bio indicates a positive outlook for the company, which has led to an increase in the trading of its shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100